Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$10.11 - $16.54 $6.4 Million - $10.5 Million
-632,596 Reduced 52.3%
576,975 $9.31 Million
Q2 2020

Aug 13, 2020

SELL
$37.05 - $65.03 $32.5 Million - $57 Million
-877,152 Reduced 42.03%
1,209,571 $72.2 Million
Q4 2019

Feb 13, 2020

SELL
$31.7 - $69.93 $31.3 Million - $69.1 Million
-988,102 Reduced 32.14%
2,086,723 $130 Million
Q3 2019

Nov 14, 2019

SELL
$19.95 - $38.85 $20.5 Million - $40 Million
-1,029,315 Reduced 25.08%
3,074,825 $104 Million
Q3 2017

Nov 14, 2017

BUY
$17.65 - $18.99 $72.4 Million - $77.9 Million
4,104,140
4,104,140 $77.9 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track New Leaf Venture Partners, L.L.C. Portfolio

Follow New Leaf Venture Partners, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.